Physician profile
Patrick Earl Jerkins
NPI 1871888339
$413.45
in general payments reported to CMS, 2019-2025
15 companies · $149 in 2025
The $149 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $110 · 2023: $67.49 · 2024: $87.31 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $303.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $80.46 | 2022-2024 | Durolane, Durolane |
| Stryker Corporation | $41.67 | 2025 | Clottriever Bold Catheter |
| Pacira Pharmaceuticals Incorporated | $39.62 | 2023-2024 | Iovera, Exparel, Zilretta |
| Treace Medical Concepts, INC. | $37.13 | 2025 | |
| Orthofix Medical, INC. | $30.95 | 2024-2025 | Physio-Stim, Accelstim |
| Depuy Synthes Sales INC. | $24.96 | 2024 | Monovisc |
| Vericel Corporation | $24.20 | 2023 | Maci |
| Ethicon US, LLC | $22.56 | 2025 | Ethicon, Vistaseal |
| Nevro Corp. | $21.74 | 2022 | |
| Breg, INC | $18.63 | 2022 | |
| Endo USA, INC. | $15.73 | 2025 | Xiaflex |
| Pfizer INC. | $15.52 | 2022 | |
| Amgen INC. | $14.58 | 2022 | |
| Checkpoint Surgical, INC | $13.62 | 2025 | Checkpoint Stimulators |
| Ferring Pharmaceuticals INC. | $12.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Jerkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.